机译:接种后 1 年造血干细胞移植和细胞治疗受者 SARS-CoV-2 反应性抗体减弱、增强作用和突破性 SARS-CoV-2 感染
Hematol Dept,Hosp Clin Univ Valencia;
Hematol Div,Hosp St Creu i St Pau;
CIBERONC,Univ Hosp Salamanca HUS IBSALHematol Div,Hosp Univ & Politecn La FeHosp Univ Infanta Leonor,Univ Complutense MadridFdn INCL,Inst Invest Sanitaria Hosp Clin Univ ValenciaHematopoiet Stem Cell Transplantat & Cell TherapyInst Catala Oncol,Hosp Duran i reynalsHematol Div,Hosp Reg Univ Carlos HayaHematol Div,Hosp Clin Univ Virgen ArrixacaHematol Div,Hosp Clin Univ Lozano BlesaHematol Div,Hosp Univ Fdn AlcorconHematol Div,Hosp Gen universitari ElxHematol Div,Hosp Ramon & Cajal;